Zargis is a global medical device company focused on improving health outcomes and cost effectiveness through diagnostic support software and technological innovation. The company was formed when Siemens AG (NYSE: SI), and Speedus Corp. co-invested to develop and market computer-aided medical devices for use in diagnostic cardiac screening and telemedicine.
In August of 2009, in collaboration with 3M™ Littmann® Brand Products, Zargis launched Cardioscan, the world's first FDA-cleared medical device to identify and classify suspected heart murmurs. In November of the same year, Cardioscan and the Bluetooth®-enabled 3M™ Littmann® Electronic Stethoscope Model 3200, which were designed to integrate with one another, were jointly named Popular Science “Innovation of the Year”.
In April, 2011, 3M Company acquired Zargis’ Cardioscan, StethAssist® and TeleSteth™ devices. Zargis is now an authorized 3M distributor of Cardioscan and the Model 3200 Stethoscope.
"I am very pleased that the Long Branch school district is the first school in the country to incorporate Cardioscan into student physicals."
Dr. Richard DeGroote, Children's Hospital at Monmouth Medical Center, NJ